The Efficacy of Hepatic Arterial Infusion Chemotherapy (HAIC) Combine Lenvatinib and Durvalumab (HILL) in Advanced Hepatocellular Carcinoma (HCC)
Clinical trial NCT04961918 · UNKNOWN
Trial details
- NCT number
- NCT04961918
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-13
- Primary completion
- 2022-07-13
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.